Vivos (RDGL) Revenue (2010 - 2025)

Vivos (RDGL) reported Revenue of $24752.0 for Q4 2025, up 395.54% on a YoY basis from $4995.0 in Q4 2024, and up 1217.3% sequentially from $1879.0 in Q3 2025.

Vivos (RDGL) Revenue (2010 - 2025) Analysis & Trends

Vivos (RDGL) has 15 years of Revenue data on file, last reported at $24752.0 in Q4 2025.

  • For the quarter ending Q4 2025, Revenue rose 395.54% year-over-year to $24752.0; the trailing twelve-month figure through Dec 2025 stood at $68379.0 (up 144.25% YoY), and the FY2025 full-year result was $68379.0, up 144.25% from the prior year.
  • Revenue advanced to $24752.0 in Q4 2025, from $1879.0 in the prior quarter.
  • In the past five years, Revenue ranged from a high of $26748.0 in Q1 2025 to a low of $1879.0 in Q3 2025.
  • A 5-year average of $10453.8 and a median of $6750.0 in 2022 frame the typical range for Revenue.
  • Peak annual rise in Revenue reached 494.4% in 2025, while the deepest fall reached 62.42% in 2025.
  • Tracing RDGL's Revenue over 5 years: stood at $14887.0 in 2021, then tumbled by 56.34% to $6499.0 in 2022, then increased by 7.71% to $7000.0 in 2023, then dropped by 28.64% to $4995.0 in 2024, then jumped by 395.54% to $24752.0 in 2025.
  • Business Quant data shows RDGL's Revenue at $24752.0 in Q4 2025, $1879.0 in Q3 2025, and $15000.0 in Q2 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Revenue (Qtr)
1 Abbott Laboratories 201.40 Bn 194.75 Bn 6.27 Bn 11.16 Bn
2 Stryker 122.29 Bn 119.41 Bn 3.81 Bn 6.02 Bn
3 Medtronic 105.01 Bn 96.40 Bn 6.41 Bn 9.81 Bn
4 Boston Scientific 64.81 Bn 63.59 Bn 3.61 Bn 5.20 Bn
5 Edwards Lifesciences 55.28 Bn 51.60 Bn 1.29 Bn 1.65 Bn
6 Dexcom 29.06 Bn 27.94 Bn 750.30 Mn 1.19 Bn
7 Koninklijke Philips 29.02 Bn 25.93 Bn 2.07 Bn 4.57 Bn
8 GE HealthCare Technologies 28.27 Bn 26.20 Bn 1.98 Bn 5.13 Bn
9 Smith & Nephew 25.80 Bn 25.22 Bn - -
10 Vivos 27.16 Mn 25.60 Mn -3,105.00 24,752.00

Historic Data

Download Data
DateValue
Dec 31, 2025 24,752.00
Sep 30, 2025 1,879.00
Jun 30, 2025 15,000.00
Mar 31, 2025 26,748.00
Dec 31, 2024 4,995.00
Sep 30, 2024 5,000.00
Jun 30, 2024 13,500.00
Mar 31, 2024 4,500.00
Sep 30, 2023 7,000.00
Jun 30, 2023 6,500.00
Mar 31, 2023 6,000.00
Dec 31, 2022 6,499.00
Sep 30, 2022 6,500.00
Jun 30, 2022 10,500.00
Mar 31, 2022 13,000.00
Sep 30, 2021 14,887.00
Sep 30, 2020 7,000.00
Dec 31, 2019 1,500.00
Sep 30, 2019 8,000.00
Mar 31, 2017 4,054.00